FIP works closely with the press to support accurate, timely and impactful reporting on pharmacy practice, pharmacy education and pharmaceutical science and global health developments. FIP provides journalists and media professionals with access to policy developments, research, publications, campaigns and initiatives shaping health care worldwide.
FIP also supports media engagement through dedicated press registration and press benefits during the annual FIP world congress, offering accredited journalists opportunities to access scientific sessions, interviews with global pharmacy leaders and key developments from across the profession.
If you would like to join our press list to receive press releases, please email press@fip.org with your name, publication, job title and email address.
Cape Town • 4 September 2024
Governments should ensure that access to medicines and medical devices is always accompanied by access to pharmacists and pharmaceutical expertise, the International Pharmaceutical Federation (FIP) says in a statement of policy, published today.
With this statement, FIP makes a number of recommendations for how different groups of stakeholders can improve access to safe and quality essential medicines. For example, policymakers should make legislative changes to enable pharmacists to provide substitutes when a prescribed medicine is not available.
In particular, the policy highlights a significant difference in medicines access between low- and high-income countries, with disparities in the structure of healthcare systems and the numbers and roles of pharmacists and pharmacies being among the contributing causes. “In terms of healthcare infrastructure, governments should strive for national health policies that ensure universal health coverage. They should also guarantee that the security of supply of medicines is central to every law ensuring access to medicines — even in the event of public health emergencies — and establish robust recall systems,” said Mr Lars-Åke Söderlund, FIP’s vice president and co-chair of the FIP committee on access to medicines.
Among the recommendations to pharmacists are that they take a leadership role in advocating medicines safety, and that they involve themselves with processes that support equitable access to medicines, including working with governments to develop policies supporting underserved populations.
“Our recommendations to address the disparities include that the pharmaceutical industry should support local production of medicines and medical devices in low- and middle-income countries through technology transfer, sharing of intellectual property, training and investment in facilities. It should also improve transparency regarding pricing structures and costs within pharmaceutical markets for governments, policymakers, health professionals and the public, and give focus to fair pricing,” Mr Söderlund added.
FIP itself makes a number of commitments in the statement, including to advocate for a regulatory and policy framework that enables pharmacists to exercise their professional competence to increase access to medicines and medical devices. The federation also commits to support competency development programmes targeting pharmacists’ roles in mitigating the impact of medicines shortages in industry, hospital, healthcare facility and community settings.
Notes for editors
About FIP
The International Pharmaceutical Federation (FIP) is the global federation of national associations of pharmacists, pharmaceutical scientists and pharmacy educators, and is in official relations with the World Health Organization. Through its 160 member organisations, it represents over four million practitioners and scientists around the world. www.fip.org
PRESS CONTACT
Lin-Nam Wang, Head of Communications and Advocacy
International Pharmaceutical Federation (FIP)
Email linnam@fip.org
Tel +31 70 302 1987